Tang L H, Luque E A, Efstathiou J A, Bortecen K H, Kidd M, Tarasova N I, Modlin I M
Department of Surgery, Yale University School of Medicine, and the Department of Veterans Affairs Medical Center, New Haven, CT 06520, USA.
Regul Pept. 1997 Sep 26;72(1):9-18. doi: 10.1016/s0167-0115(97)01025-2.
The enterochromaffin-like cell (ECL) cells of the stomach are principally regulated by gastrin via a gastrin/CCK(B) receptor (G[R]) which modulates both histamine secretion and cell proliferation. In the African rodent (mastomys) hypergastrinemia generated by the histamine-2 receptor antagonist (loxtidine) results in ECL cell hyperplasia and neoplasia at 8 and 16 weeks respectively. The expression, structure and function of the G(R) during transformation is however unknown. We utilized a pure (approximately 90%) preparation of ECL cells to evaluate alterations in the G(R) utilizing immunocytochemistry, Western blot analysis, reverse transcription polymerase chain reaction (RT-PCR), 5-bromo-2-deoxyuridine uptake and phosphorylation site analysis. Although the expression of ECL cell G(R) was upregulated at both mRNA (PT-PCR) and protein (Western analysis) level, its affinity to gastrin was decreased in the hyperplastic phase and lost during transformation. The coding sequence of the G(R) of mastomys tumor ECL cells was identical to that of normal ECL cells, parietal cells and the brain. However, the mRNA sequence of the third introcytoplasmic loop of the G(R) was significantly different to other species. In addition, the G(R) exhibited phosphorylation site on serine residue(s). We have thus noted a direct correlation between hypergastrinemia and G(R) alteration and function during ECL cell transformation. It is possible that the unique mastomys gastrin receptor mediated ECL cell transformation involves the novel phosphorylation sites and a divergence in the introcytoplasmic domain.
胃的肠嗜铬样细胞(ECL细胞)主要受胃泌素通过胃泌素/CCK(B)受体(G[R])调节,该受体可调节组胺分泌和细胞增殖。在非洲啮齿动物(多乳鼠)中,组胺-2受体拮抗剂(洛替丁)产生的高胃泌素血症分别在8周和16周时导致ECL细胞增生和肿瘤形成。然而,转化过程中G(R)的表达、结构和功能尚不清楚。我们利用纯度约为90%的ECL细胞制剂,通过免疫细胞化学、蛋白质印迹分析、逆转录聚合酶链反应(RT-PCR)、5-溴-2-脱氧尿苷摄取和磷酸化位点分析来评估G(R)的变化。虽然ECL细胞G(R)在mRNA(PT-PCR)和蛋白质(蛋白质印迹分析)水平上均上调,但其在增生期对胃泌素的亲和力降低,并在转化过程中丧失。多乳鼠肿瘤ECL细胞G(R)的编码序列与正常ECL细胞、壁细胞和脑的编码序列相同。然而,G(R)第三个胞质内环的mRNA序列与其他物种有显著差异。此外,G(R)在丝氨酸残基上显示出磷酸化位点。因此,我们注意到高胃泌素血症与ECL细胞转化过程中G(R)的改变和功能之间存在直接相关性。独特的多乳鼠胃泌素受体介导的ECL细胞转化可能涉及新的磷酸化位点和胞质内结构域的差异。